feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Thyroid Cancer: Treatable When Caught Early

Thyroid Cancer: Treatable When Caught Early

22 Jan

•

Summary

  • Early detection significantly boosts survival rates for thyroid cancer.
  • There are five main types of thyroid cancer, each managed differently.
  • Papillary thyroid cancer, the most common, has over 95% survival.
Thyroid Cancer: Treatable When Caught Early

Thyroid cancer is among the most treatable cancers, especially when diagnosed early. The butterfly-shaped thyroid gland, essential for metabolism, can develop abnormal cells forming distinct cancer types, each requiring tailored treatment. Doctors emphasize that thyroid cancer is not a single disease; its behavior dictates its management.

Globally, thyroid cancer incidence is rising, partly due to improved detection methods like ultrasound and fine-needle biopsies. The World Health Organization highlights that early diagnosis dramatically improves outcomes, with survival rates often exceeding 90% for common types.

Papillary thyroid cancer, accounting for 80% of cases, is slow-growing and highly responsive to treatment, with survival rates above 95% for early stages. Follicular thyroid cancer, the second most common, is also treatable with early intervention, though it may spread through the bloodstream.

trending

Nurses infected with Nipah virus

trending

Gold, silver prices fall

trending

AFCAT 1 admit card released

trending

SIDBI gets ₹5,000 cr boost

trending

FSSAI enforcement has limited impact

trending

Hang Seng Index rises

trending

IIFL shares plunge after tax

trending

India Post expands ATM network

trending

NEET PG 2026: Exam Dates

Hurthle cell carcinoma, a rarer and more aggressive variant, requires careful monitoring and surgery as it doesn't always respond to radioactive iodine. Medullary thyroid cancer, representing 3-4% of cases, has genetic links and does not respond to radioactive iodine, necessitating genetic testing and early surgical removal.

Anaplastic thyroid cancer, the least common (under 2%) and most aggressive form, demands immediate, intensive treatment combining surgery, radiation, and chemotherapy, with emerging targeted therapies offering new hope. Recognizing early symptoms like a painless neck lump or persistent hoarseness and seeking prompt medical evaluation is vital for successful management and a good quality of life post-treatment.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The article discusses Papillary, Follicular, Hurthle Cell, Medullary, and Anaplastic thyroid cancers.
Yes, thyroid cancer is highly treatable, especially when detected early, with survival rates often exceeding 90%.
Early symptoms can include a painless lump in the neck, hoarseness, difficulty swallowing, or unexplained neck swelling.

Read more news on

Healthside-arrow

You may also like

Thyroid Cancer: The Silent Epidemic Rising

20 Jan • 7 reads

article image

New Therapy Turns Cancer's Allies Against It

11 Jan • 60 reads

article image

Itchy Skin? Could It Be Cancer?

8 Jan • 61 reads

article image

Marisa Abela's Cancer Battle: 'Career Over' Fears

5 Jan • 70 reads

article image

Cancer Treatment Timing Matters: Early Doses Boost Survival

23 Dec, 2025 • 134 reads

article image